Participated in the Inaugural Conference and Symposium of the Japanese Society of Preemptive Clinical Medicine
The event was held yesterday, June 2-3, at Yumebutai on Awaji Island, The Japanese Society of Preemptive Clinical Medicine, Inc.We participated in the inaugural conference and symposium of the The main theme was “Strategies for the Cancer and Refugee Sphere. The Japan Association for Preemptive Medicine was newly established in April this year. Many of the study group’s professors were in attendance, as some of them serve on the board of directors. In the symposium, Dr. Kato, who is the executive director of the study group, gave a lecture on the “Cancer and Refugee Sphere”,Luke’s Ashiya ClinicFrom Masahiko Shirotani, Director of“Usefulness of intestinal flora transplantation (fecal flora transplantation) using special bacterial solutions.”There was a presentation on the We also presented a clinical report on intestinal flora transplantation and the water used for the bacterial solution. We are now conducting experiments on mice to study the usefulness of the bacteria solution, and we plan to report on the results at the general meeting to be held in October. This was an opportunity for many medical professionals to learn about the possibility of intestinal flora transplantation.▼ Presentation by Dr. Shirotani

Exhibited a booth at the venue!

▼ From left: Dr. Kawai from Kawai Naika Clinic, Dr. Zen Tanaka from Tanaka Clinic,
Dr. Masayuki Holm Oe from Life Clinic and Ms. Mayumi Sakamoto from Council Member
その他の Notices and Activity Reports に関する記事
Articles about other Notices and Activity Reports

October 06, 2026
Survey Summary from the 10th Annual Academic Conference
The 10th Annual Academic Conference was held on September 27, 2026.The event was conducted in a hybrid format, both on-site and online, with close to 150 participants in total, including healthcare professionals, corporate representatives, research institution staff, and even patients, their families, and members of the general public. In this article, we share the results […]

September 28, 2026
10th Scientific Conference of the Association for Clinical Research of Fecal Microbiota Transplantation Japan [Event Report]
The Association for Clinical Research of Fecal Microbiota Transplantation Japan (General Incorporated Foundation) held its 10th Scientific Conference on Sunday, 27 September 2026. At this milestone 10th conference, we presented the latest findings and clinical data on “NanoGAS®-FMT” across a wide range of clinical fields, including cancer, gastroenterology, neurodevelopmental disorders and endoscopic examinations, for those […]

October 28, 2024
〈Clinical Trial〉Completion Report
We are pleased to report the completion of the specified clinical trial titled “Specified Clinical Trial on the Efficacy and Safety of a Novel Fecal Microbiota Transplantation Method for Autism Spectrum Disorder,” which was initiated by our research group in May 2023. This specified clinical trial is published on the jRCT (Japan Registry of Clinical […]
